Table 2 hsp60 cluster classification and prevalence of CST-resistant ECC clinical isolates
hsp60 cluster | No. of ECC isolates (percentage among ECC isolates) | No. of CST-resistant isolates (percentage among each cluster) |
|---|---|---|
I | 25 (18.1%) | 8 (32.0%) |
II | 15 (10.9%) | 14 (93.3%) |
III | 3 (2.2%) | 1 (33.3%) |
IV | 9 (6.5%) | 9 (100%) |
V | 27 (19.6%) | 0 (0%) |
VI | 17 (12.3%) | 0 (0%) |
VIII | 34 (24.6%) | 0 (0%) |
IX | 4 (2.9%) | 3 (75.0%) |
XI | 1 (0.7%) | 1 (100%) |
XII | 2 (1.4%) | 2 (100%) |
XIII | 1 (0.7%) | 0 (0%) |